| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| cd123/cll1 car-t cells | myeloid inhibitory c-type lectin-like receptor | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Leukemia Myelocytic Acute[MeSHID:D015470] T-Lymphocyte[MeSHID:D013601] |
NA | phase 2/3 | unknown |
| cd123/cll1 car-t cells | interleukin 3 receptor alpha | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Leukemia Myelocytic Acute[MeSHID:D015470] T-Lymphocyte[MeSHID:D013601] |
NA | phase 2/3 | unknown |
| click here to return to the previous page | ||||||||